Results 171 to 180 of about 67,411 (205)

Preoperative Chemoradiotherapy with Tegafur-Uracil, Capecitabine, or 5-Fluorouracil/Leucovorin for Rectal Cancer in an Asian Cohort: A Real-World Comparison from the Pre-TNT Era. [PDF]

Curr Oncol
Dai KY, Chen FY, Liu CK, Lin J, Liu SH.
europepmc   +1 more source

Efficacy of Ninjin'yoeito in Adjuvant Chemotherapy for Colorectal Cancer: A Retrospective Clinical Study with Propensity Score Matching Analysis. [PDF]

J Anus Rectum Colon
Kasahara K, Mazaki J, Sujino H, Kuboyama Y, Udo R, Tago T, Osakabe H, Kuwabara H, Iwasaki K, Koga H, Kanazawa A, Nagakawa Y.   +11 more
europepmc   +1 more source

Developing and evaluating definitions of real-world clinical endpoints for patients with early-stage triple-negative breast cancer using a United States of America secondary database. [PDF]

ESMO Real World Data Digit Oncol
Hu X, Earla JR, Cruz GI, Mohammed H, Privette T, Hernandez A, Krishnan R, Pan W, Haiderali A.   +8 more
europepmc   +1 more source

Pancreatic ductal adenocarcinoma with ITSN1-ALK fusion: sustained response to alectinib with 19-month progression-free survival. [PDF]

Oncologist
Liu C, Wang X, Chen L.
europepmc   +1 more source

Two lives, one fight: navigating rectal cancer in pregnancy with multidisciplinary precision. [PDF]

Ann Coloproctol
Jearanai S, Malakorn S.
europepmc   +1 more source

DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer. [PDF]

Clin Cancer Res
Jhaveri K, Loi S, Hamilton E, Schmid P, Anders CK, Testa L, Wildiers H, Tseng LM, Lu YS, Park YH, Im SA, Chen SC, Young RR, Lloyd C, Wrona M, Zhang C, Carroll D, André F.   +17 more
europepmc   +1 more source

Recurrent hyperammonemic encephalopathy in a breast cancer patient receiving capecitabine therapy: a case report and literature review. [PDF]

Front Pharmacol
Mu Y, Li Q, Kong J, Zhao Y.
europepmc   +1 more source

Safety and efficacy of PEG-rhG-CSF as primary prophylaxis for neutropenia in gastrointestinal cancer patients receiving combination chemotherapy including oral agents: a prospective, exploratory, non-randomized controlled study. [PDF]

Front Oncol
Wang H, Zhang X, Du Y, Liu M, Ma N, Gao Y, Wang M, Cai L, Feng T, Yang S, Hu W, Zhang G, Zhao J.   +12 more
europepmc   +1 more source

Survival outcomes and prognostic value of nutritional and inflammatory markers in third-line treatment of metastatic pancreatic cancer. [PDF]

Front Oncol
Vidulin J, Ondruš D, Pöršök Ś, Kráčalíková M, Ušáková V, Šuták K, Miškovičová M, Kizeková M, Fremal M, Pisáková J, Kecskés I, Lešková J, Bystrický B.   +12 more
europepmc   +1 more source

Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals. [PDF]

Cureus
Freitas R, Barroso T, Braga S, Santos CC, Batista M, Chaves A, Cabral S, Fortuna A, Patel V, Araújo J, Duarte T, Cabral TP, Silva S, Viana C, Baptista C, Gonçalves J, Dunões IQ, Eiriz I.   +17 more
europepmc   +1 more source